David Friedecký
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Biochemistry top 5%
Papers in
-
- Metabolomics and Mass Spectrometry Studies 24
- Biochemical and Molecular Research 20
- Physiology 24
- Alzheimer's disease research and treatments 9
- Co-authors
- Tomáš Adam (55 shared papers)Edgar Faber (12 shared papers)Lukáš Najdekr (13 shared papers)Petr Barták (5 shared papers)Radana Brumarová (19 shared papers)Hana Janečková (11 shared papers)Miroslav Strnad (6 shared papers)Jitka Široká (5 shared papers)
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (5 papers)Journal of Chromatography A (5 papers)Scientific Reports (4 papers)International Journal of Molecular Sciences (4 papers)Journal of Chromatography B (4 papers)
- Partner nations
- CzechiaSlovakiaNetherlands
In The Last Decade
David Friedecký
102 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 123
- Clinical Biochemistry 166
- Biochemistry 84
- Hematology 128
- Genetics 100
- Molecular Biology 632
Countries citing papers authored by David Friedecký
This map shows the geographic impact of David Friedecký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Friedecký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Friedecký more than expected).
Fields of papers citing papers by David Friedecký
This network shows the impact of papers produced by David Friedecký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Friedecký. The network helps show where David Friedecký may publish in the future.
Co-authors
The 25 scholars most cited alongside David Friedecký, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 101 | |
| 2 | 2022 | 58 | |
| 3 | 2011 | 41 | |
| 4 | 1999 | 39 | |
| 5 | 2010 | 38 | |
| 6 | 2015 | 35 | |
| 7 | 2005 | 35 | |
| 8 | 2016 | 33 | |
| 9 | 2002 | 31 | |
| 10 | 2019 | 31 | |
| 11 | 2015 | 30 | |
| 12 | 2017 | 26 | |
| 13 | 2012 | 23 | |
| 14 | 2007 | 23 | |
| 15 | 2022 | 23 | |
| 16 | 2023 | 22 | |
| 17 | 2014 | 22 | |
| 18 | 2016 | 22 | |
| 19 | 2015 | 21 | |
| 20 | 2016 | 21 |
About David Friedecký
David Friedecký is a scholar working on Molecular Biology, Physiology, Clinical Biochemistry, Rheumatology and Hematology, having authored 113 papers that have together received 1.3k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (24 papers), Biochemical and Molecular Research (20 papers), Metabolism and Genetic Disorders (20 papers), Chronic Lymphocytic Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Microfluidic and Capillary Electrophoresis Applications (10 papers), Alzheimer's disease research and treatments (9 papers) and Eosinophilic Disorders and Syndromes (9 papers). The work is most often cited by research in Clinical Biochemistry (166 citations), Biochemistry (84 citations), Hematology (128 citations), Genetics (100 citations) and Molecular Biology (632 citations). David Friedecký has collaborated with scholars based in Czechia, Slovakia and Netherlands. Frequent co-authors include Tomáš Adam, Edgar Faber, Lukáš Najdekr, Petr Barták, Radana Brumarová, Hana Janečková, Miroslav Strnad, Jitka Široká, Anna Ligasová and Karel Koberna. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Journal of Chromatography A, Scientific Reports, International Journal of Molecular Sciences and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.